Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Yoo, Hye J ^a   Hwang, Soon Y ^a   Hong, Ho C ^a   Choi, Hae Y ^a   Yang, Sae J ^a   Seo, Ji A ^a   Kim, Sin G ^a   Kim, Nan H ^a   Choi, Kyung M ^a   Choi, Dong S ^a   Baik, Sei H ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Carotid intima media thickness; Omentin 1; Pulse wave velocity; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; OMENTIN 1; SULFONYLUREA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CIGARETTE SMOKING; CLINICAL ARTICLE; FEMALE; GROUPS BY AGE; HUMAN; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; ANALYSIS OF VARIANCE; ATHEROSCLEROTIC PLAQUE; BLOOD; CAROTID ARTERY DISEASE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; DIABETIC ANGIOPATHY; DOWN REGULATION; ECHOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK; RISK ASSESSMENT; RISK FACTOR; SOUTH KOREA; STATISTICAL MODEL;

ANALYSIS OF VARIANCE; ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DOWN-REGULATION; FEMALE; GPI-LINKED PROTEINS; HUMANS; LECTINS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PLAQUE, ATHEROSCLEROTIC; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS;

EID: 81455160583     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-103     Document Type: Article

References (33)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053. 10.2337/diacare.27.5.1047, 15111519.
2. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004, 164(13):1422-1426. 10.1001/archinte.164.13.1422, 15249351.
3. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007, 27(5):996-1003. 10.1161/ATVBAHA.106.131755, 17303782.
4. Yang R, Xu A, Pray J, Hu H, Jadhao S, Hansen B, Shuldiner A, Mc-Lenithan J, Gong D. Cloning of omentin, a new adipocytokine from omental fat tissue in humans. Diabetes 2003, Suppl 1:A1.
5. Schaffler A, Neumeier M, Herfarth H, Furst A, Scholmerich J, Buchler C. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005, 1732(1-3):96-102.
6. Xiang K, Wang Y, Zheng T, Jia W, Li J, Chen L, Shen K, Wu S, Lin X, Zhang G, et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes 2004, 53(1):228-234.
7. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006, 290(6):E1253-1261. 10.1152/ajpendo.00572.2004, 16531507.
8. Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 2010, 88(1):29-33. 10.1016/j.diabres.2010.01.013, 20129687.
9. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007, 56(6):1655-1661. 10.2337/db06-1506, 17329619.
10. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H, Randeva HS. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008, 57(4):801-808. 10.2337/db07-0990, 18174521.
11. Moreno-Navarrete JM, Ortega F, Castro A, Sabater M, Ricart W, Fernandez-Real JM. Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity 2011, 19(8):1552-1559. 10.1038/oby.2010.351, 21293447.
12. Liu R, Wang X, Bu P. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract 2011, 93(1):21-25. 10.1016/j.diabres.2011.03.001, 21497934.
13. Zhong X, Zhang HY, Tan H, Zhou Y, Liu FL, Chen FQ, Shang DY. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 2011, 32(7):873-878. 10.1038/aps.2011.26, 21602837.
14. Shibata R, Takahashi R, Kataoka Y, Ohashi K, Ikeda N, Kihara S, Murohara T, Ouchi N. Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men. Hypertens Res 2011,
15. Li Q, Yang Z, Lu B, Wen J, Ye Z, Chen L, He M, Tao X, Zhang W, Huang Y, et al. Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol 2011, 10:72-79. 10.1186/1475-2840-10-72, 3163178, 21816063.
16. Shin JY, Lee HR, Lee DC. Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes. Cardiovasc Diabetol 2011, 10:30-25. 10.1186/1475-2840-10-30, 3098149, 21492487.
17. Van de Veire NR, Djaberi R, Schuijf JD, Bax JJ. Non-invasive imaging: non-invasive assessment of coronary artery disease in diabetes. Heart 2010, 96(7):560-572. 10.1136/hrt.2007.122788, 20350998.
18. Dalla Pozza R, Beyerlein A, Thilmany C, Weissenbacher C, Netz H, Schmidt H, Bechtold S. The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus. Cardiovasc Diabetol 2011, 10:53-61. 10.1186/1475-2840-10-53, 3148557, 21679428.
19. Kubo T, Miyata M, Minagoe S, Setoyama S, Maruyama I, Tei C. A simple oscillometric technique for determining new indices of arterial distensibility. Hypertens Res 2002, 25(3):351-358. 10.1291/hypres.25.351, 12135312.
20. American Diabetes Association Standards of medical care in diabetes--2010. Diabetes Care 2010, 33(Suppl 1):S11-61. 2797382, 20042772, American Diabetes Association.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
22. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002, 25(3):359-364. 10.1291/hypres.25.359, 12135313.
23. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999, 30(4):841-850. 10.1161/01.STR.30.4.841, 10187889.
24. DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010, 53(7):1270-1287. 10.1007/s00125-010-1684-1, 2877338, 20361178.
25. Yoo HJ, Kim S, Park MS, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, et al. Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography. J Clin Endocrinol Metab 2011, 96(3):E488-492. 10.1210/jc.2010-1473, 21159847.
26. Choi HY, Kim S, Yang SJ, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Association of adiponectin, resistin, and vascular inflammation: analysis with 18F-fluorodeoxyglucose positron emission tomography. Arterioscler Thromb Vasc Biol 2011, 31(4):944-949. 10.1161/ATVBAHA.110.220673, 21212400.
27. Yu YH, Ginsberg HN. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 2005, 96(10):1042-1052. 10.1161/01.RES.0000165803.47776.38, 15920027.
28. Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 2010, 20(5):143-148. 10.1016/j.tcm.2010.12.002, 21742269.
29. El-Mesallamy HO, El-Derany MO, Hamdy NM. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med 2011, 28(10):1194-1200. 10.1111/j.1464-5491.2011.03353.x, 21668495.
30. Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 2010, 393(4):668-672. 10.1016/j.bbrc.2010.02.053, 20170632.
31. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011, 408(2):339-343. 10.1016/j.bbrc.2011.04.039, 21514279.
32. Xie H, Xie PL, Wu XP, Chen SM, Zhou HD, Yuan LQ, Sheng ZF, Tang SY, Luo XH, Liao EY. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. Cardiovasc Res 2011,
33. Yan P, Liu D, Long M, Ren Y, Pang J, Li R. Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2011, 119(4):257-263. 10.1055/s-0030-1269912, 21374544.